CH620893A5 - - Google Patents
Download PDFInfo
- Publication number
- CH620893A5 CH620893A5 CH827774A CH827774A CH620893A5 CH 620893 A5 CH620893 A5 CH 620893A5 CH 827774 A CH827774 A CH 827774A CH 827774 A CH827774 A CH 827774A CH 620893 A5 CH620893 A5 CH 620893A5
- Authority
- CH
- Switzerland
- Prior art keywords
- ethyl ester
- formula
- trans
- acid ethyl
- octenyl
- Prior art date
Links
- -1 cycloaliphatic Chemical group 0.000 claims description 58
- 150000001875 compounds Chemical class 0.000 claims description 50
- 125000004432 carbon atom Chemical group C* 0.000 claims description 30
- 239000001257 hydrogen Substances 0.000 claims description 27
- 229910052739 hydrogen Inorganic materials 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 21
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 16
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 15
- 239000001301 oxygen Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 13
- 229940094443 oxytocics prostaglandins Drugs 0.000 claims description 12
- 150000003180 prostaglandins Chemical class 0.000 claims description 12
- 229920006395 saturated elastomer Polymers 0.000 claims description 12
- 229910052720 vanadium Inorganic materials 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 9
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 125000004434 sulfur atom Chemical group 0.000 claims description 6
- 125000001931 aliphatic group Chemical group 0.000 claims description 5
- 230000008602 contraction Effects 0.000 claims description 5
- 229910052987 metal hydride Inorganic materials 0.000 claims description 5
- 150000004681 metal hydrides Chemical class 0.000 claims description 5
- 239000000010 aprotic solvent Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 230000000144 pharmacologic effect Effects 0.000 claims description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 238000005804 alkylation reaction Methods 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 3
- 150000007524 organic acids Chemical class 0.000 claims description 3
- 210000002460 smooth muscle Anatomy 0.000 claims description 3
- 239000011593 sulfur Substances 0.000 claims description 3
- 241000251730 Chondrichthyes Species 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 230000029936 alkylation Effects 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 230000036772 blood pressure Effects 0.000 claims 1
- 125000001511 cyclopentyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 229930014626 natural product Natural products 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 189
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 111
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 81
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 77
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 59
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 48
- 238000002474 experimental method Methods 0.000 description 47
- 239000000243 solution Substances 0.000 description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- 239000000203 mixture Substances 0.000 description 33
- 238000006243 chemical reaction Methods 0.000 description 29
- 229960000583 acetic acid Drugs 0.000 description 28
- 239000012362 glacial acetic acid Substances 0.000 description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 22
- UWSJCCUODNDXOT-UHFFFAOYSA-N ethyl cyclopentanecarboxylate Chemical compound CCOC(=O)C1CCCC1 UWSJCCUODNDXOT-UHFFFAOYSA-N 0.000 description 22
- 239000012074 organic phase Substances 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 229910004298 SiO 2 Inorganic materials 0.000 description 17
- 238000001816 cooling Methods 0.000 description 17
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 17
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 16
- 239000000741 silica gel Substances 0.000 description 16
- 229910002027 silica gel Inorganic materials 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- 238000003756 stirring Methods 0.000 description 15
- 238000004587 chromatography analysis Methods 0.000 description 14
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 14
- 238000010992 reflux Methods 0.000 description 14
- 125000004494 ethyl ester group Chemical group 0.000 description 13
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 238000009835 boiling Methods 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 229910000104 sodium hydride Inorganic materials 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 230000007717 exclusion Effects 0.000 description 5
- 210000003405 ileum Anatomy 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- 239000011877 solvent mixture Substances 0.000 description 5
- 210000004291 uterus Anatomy 0.000 description 5
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000012230 colorless oil Substances 0.000 description 4
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 4
- 229960002986 dinoprostone Drugs 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- ODUCDPQEXGNKDN-UHFFFAOYSA-N nitroxyl Chemical compound O=N ODUCDPQEXGNKDN-UHFFFAOYSA-N 0.000 description 4
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- MNWBNISUBARLIT-UHFFFAOYSA-N sodium cyanide Chemical compound [Na+].N#[C-] MNWBNISUBARLIT-UHFFFAOYSA-N 0.000 description 4
- 235000009518 sodium iodide Nutrition 0.000 description 4
- IBODDUNKEPPBKW-UHFFFAOYSA-N 1,5-dibromopentane Chemical compound BrCCCCCBr IBODDUNKEPPBKW-UHFFFAOYSA-N 0.000 description 3
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 3
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000003431 anti-prostaglandin Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- UPQZOUHVTJNGFK-UHFFFAOYSA-N diethyl 2-methylpropanedioate Chemical compound CCOC(=O)C(C)C(=O)OCC UPQZOUHVTJNGFK-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- MVCSLDOOVLPFQU-UHFFFAOYSA-N ethyl 2-(2-iodoethoxy)acetate Chemical compound CCOC(=O)COCCI MVCSLDOOVLPFQU-UHFFFAOYSA-N 0.000 description 3
- MQGNUJBUFJNMJZ-UHFFFAOYSA-N ethyl 2-ethyl-6-iodohexanoate Chemical compound CCOC(=O)C(CC)CCCCI MQGNUJBUFJNMJZ-UHFFFAOYSA-N 0.000 description 3
- BZLVOUTZDHRJPD-UHFFFAOYSA-N ethyl 4-(2-bromoethoxy)benzoate Chemical compound CCOC(=O)C1=CC=C(OCCBr)C=C1 BZLVOUTZDHRJPD-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000006408 oxalic acid Nutrition 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 description 2
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 2
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 2
- CLAQMWDLICXNBF-UHFFFAOYSA-N 2-methyl-6-phenoxyhexanoic acid Chemical compound OC(=O)C(C)CCCCOC1=CC=CC=C1 CLAQMWDLICXNBF-UHFFFAOYSA-N 0.000 description 2
- CKLYBTLKNBKSIE-UHFFFAOYSA-N 3-[4-(hydroxymethyl)phenyl]propanoic acid Chemical compound OCC1=CC=C(CCC(O)=O)C=C1 CKLYBTLKNBKSIE-UHFFFAOYSA-N 0.000 description 2
- SZQVEGOXJYTLLB-UHFFFAOYSA-N 3-cyclopentylpropanoyl chloride Chemical compound ClC(=O)CCC1CCCC1 SZQVEGOXJYTLLB-UHFFFAOYSA-N 0.000 description 2
- QPNPRTVIMXYXIQ-UHFFFAOYSA-N 4-methylheptanedioic acid Chemical compound OC(=O)CCC(C)CCC(O)=O QPNPRTVIMXYXIQ-UHFFFAOYSA-N 0.000 description 2
- MYHIUHVVGZGAEA-UHFFFAOYSA-N 7-bromo-3-methylheptanoic acid Chemical compound OC(=O)CC(C)CCCCBr MYHIUHVVGZGAEA-UHFFFAOYSA-N 0.000 description 2
- MUEYPWVODMKZOU-UHFFFAOYSA-N 7-bromo-5-methylheptanoic acid Chemical compound BrCCC(C)CCCC(O)=O MUEYPWVODMKZOU-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910010084 LiAlH4 Inorganic materials 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- OUMBMFMVAXFDPS-UHFFFAOYSA-N ethyl 2-(3-iodopropoxy)acetate Chemical compound CCOC(=O)COCCCI OUMBMFMVAXFDPS-UHFFFAOYSA-N 0.000 description 2
- JPFPABIOARWYSO-UHFFFAOYSA-N ethyl 2-(4-iodobutoxy)propanoate Chemical compound CCOC(=O)C(C)OCCCCI JPFPABIOARWYSO-UHFFFAOYSA-N 0.000 description 2
- UWDKWYPBYBZYGJ-UHFFFAOYSA-N ethyl 2-butyl-6-iodohexanoate Chemical compound CCCCC(C(=O)OCC)CCCCI UWDKWYPBYBZYGJ-UHFFFAOYSA-N 0.000 description 2
- LTOCGTRWDBPFIW-UHFFFAOYSA-N ethyl 2-butyl-7-iodoheptanoate Chemical compound CCCCC(C(=O)OCC)CCCCCI LTOCGTRWDBPFIW-UHFFFAOYSA-N 0.000 description 2
- MAIIGWMWGDOBEQ-UHFFFAOYSA-N ethyl 2-ethyl-5-iodopentanoate Chemical compound CCOC(=O)C(CC)CCCI MAIIGWMWGDOBEQ-UHFFFAOYSA-N 0.000 description 2
- DDHGSRNWKLRKDO-UHFFFAOYSA-N ethyl 2-ethyl-7-iodoheptanoate Chemical compound CCOC(=O)C(CC)CCCCCI DDHGSRNWKLRKDO-UHFFFAOYSA-N 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- KPLQWLMUJRCHGB-UHFFFAOYSA-N ethyl 3-(3-iodopropoxy)butanoate Chemical compound CCOC(=O)CC(C)OCCCI KPLQWLMUJRCHGB-UHFFFAOYSA-N 0.000 description 2
- RDYHQEDCLHYJBY-UHFFFAOYSA-N ethyl 4-(2-iodoethoxy)benzoate Chemical compound CCOC(=O)C1=CC=C(OCCI)C=C1 RDYHQEDCLHYJBY-UHFFFAOYSA-N 0.000 description 2
- HJOKHYAUMWNBJB-UHFFFAOYSA-N ethyl 4-(3-bromopropyl)benzoate Chemical compound CCOC(=O)C1=CC=C(CCCBr)C=C1 HJOKHYAUMWNBJB-UHFFFAOYSA-N 0.000 description 2
- GXANORVTQGAGCE-UHFFFAOYSA-N ethyl 4-(3-iodopropyl)benzoate Chemical compound CCOC(=O)C1=CC=C(CCCI)C=C1 GXANORVTQGAGCE-UHFFFAOYSA-N 0.000 description 2
- TWQLMAJROCNXEA-UHFFFAOYSA-N ethyl 4-(bromomethyl)benzoate Chemical compound CCOC(=O)C1=CC=C(CBr)C=C1 TWQLMAJROCNXEA-UHFFFAOYSA-N 0.000 description 2
- DMKKSWBNCUUYSP-UHFFFAOYSA-N ethyl 4-[2-(bromomethyl)phenyl]butanoate Chemical compound CCOC(=O)CCCC1=CC=CC=C1CBr DMKKSWBNCUUYSP-UHFFFAOYSA-N 0.000 description 2
- XXPZQPNSLHBJBG-UHFFFAOYSA-N ethyl 4-iodo-3-methylbutanoate Chemical compound CCOC(=O)CC(C)CI XXPZQPNSLHBJBG-UHFFFAOYSA-N 0.000 description 2
- BUUFQDFMEOSXBM-UHFFFAOYSA-N ethyl 5-iodo-2-methylpentanoate Chemical compound CCOC(=O)C(C)CCCI BUUFQDFMEOSXBM-UHFFFAOYSA-N 0.000 description 2
- RUVQSRJJSDAXER-UHFFFAOYSA-N ethyl 5-iodopentanoate Chemical compound CCOC(=O)CCCCI RUVQSRJJSDAXER-UHFFFAOYSA-N 0.000 description 2
- OFTZSBMOIQQQRY-UHFFFAOYSA-N ethyl 6-iodo-2-methylhexanoate Chemical compound CCOC(=O)C(C)CCCCI OFTZSBMOIQQQRY-UHFFFAOYSA-N 0.000 description 2
- LTWOHZNXCOUWKH-UHFFFAOYSA-N ethyl 6-iodohexanoate Chemical compound CCOC(=O)CCCCCI LTWOHZNXCOUWKH-UHFFFAOYSA-N 0.000 description 2
- BSISUMFLNHRBCA-UHFFFAOYSA-N ethyl 7-bromo-3-methylheptanoate Chemical compound CCOC(=O)CC(C)CCCCBr BSISUMFLNHRBCA-UHFFFAOYSA-N 0.000 description 2
- UGBNRKMVWGZCCF-UHFFFAOYSA-N ethyl 7-bromo-5-methylheptanoate Chemical compound CCOC(=O)CCCC(C)CCBr UGBNRKMVWGZCCF-UHFFFAOYSA-N 0.000 description 2
- AMFHTHUKANBQQV-UHFFFAOYSA-N ethyl 7-bromo-6-methylhept-5-enoate Chemical compound CCOC(=O)CCCC=C(C)CBr AMFHTHUKANBQQV-UHFFFAOYSA-N 0.000 description 2
- BKDFYJSPBRCMOO-UHFFFAOYSA-N ethyl 7-hydroxy-4-methylheptanoate Chemical compound CCOC(=O)CCC(C)CCCO BKDFYJSPBRCMOO-UHFFFAOYSA-N 0.000 description 2
- QFYJRIXEPZDAMN-UHFFFAOYSA-N ethyl 7-iodo-2-methylheptanoate Chemical compound CCOC(=O)C(C)CCCCCI QFYJRIXEPZDAMN-UHFFFAOYSA-N 0.000 description 2
- ZMWTYBNGMOFAKH-UHFFFAOYSA-N ethyl 7-iodo-3-methylheptanoate Chemical compound CCOC(=O)CC(C)CCCCI ZMWTYBNGMOFAKH-UHFFFAOYSA-N 0.000 description 2
- SRTPSJHUBPEFKO-UHFFFAOYSA-N ethyl 7-iodo-4-methylheptanoate Chemical compound CCOC(=O)CCC(C)CCCI SRTPSJHUBPEFKO-UHFFFAOYSA-N 0.000 description 2
- BJEXNYYARCKDOE-UHFFFAOYSA-N ethyl 7-iodo-5-methylheptanoate Chemical compound CCOC(=O)CCCC(C)CCI BJEXNYYARCKDOE-UHFFFAOYSA-N 0.000 description 2
- HYNNFHYYEVPUMG-UHFFFAOYSA-N ethyl 8-iodooctanoate Chemical compound CCOC(=O)CCCCCCCI HYNNFHYYEVPUMG-UHFFFAOYSA-N 0.000 description 2
- UKFXDFUAPNAMPJ-UHFFFAOYSA-N ethylmalonic acid Chemical compound CCC(C(O)=O)C(O)=O UKFXDFUAPNAMPJ-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- XLSMFKSTNGKWQX-UHFFFAOYSA-N hydroxyacetone Chemical compound CC(=O)CO XLSMFKSTNGKWQX-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- PLYMOQWSZDXNHO-UHFFFAOYSA-N methyl 2-(4-iodobutoxy)acetate Chemical compound COC(=O)COCCCCI PLYMOQWSZDXNHO-UHFFFAOYSA-N 0.000 description 2
- ZIYVHBGGAOATLY-UHFFFAOYSA-N methylmalonic acid Chemical compound OC(=O)C(C)C(O)=O ZIYVHBGGAOATLY-UHFFFAOYSA-N 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 230000003033 spasmogenic effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- NXWYAHLLQFLYDY-ZETCQYMHSA-N (2s)-2-(diethylamino)pentanedioic acid Chemical compound CCN(CC)[C@H](C(O)=O)CCC(O)=O NXWYAHLLQFLYDY-ZETCQYMHSA-N 0.000 description 1
- KXOSCUOULVSZQD-UHFFFAOYSA-N (6-chloro-5-methylhexoxy)benzene Chemical compound ClCC(C)CCCCOC1=CC=CC=C1 KXOSCUOULVSZQD-UHFFFAOYSA-N 0.000 description 1
- RMXLHIUHKIVPAB-OWOJBTEDSA-N (e)-1,4-dibromobut-2-ene Chemical compound BrC\C=C\CBr RMXLHIUHKIVPAB-OWOJBTEDSA-N 0.000 description 1
- KFSQJVOLYQRELE-HWKANZROSA-N (e)-2-ethylbut-2-enoic acid Chemical compound CC\C(=C/C)C(O)=O KFSQJVOLYQRELE-HWKANZROSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- ROUYUBHVBIKMQO-UHFFFAOYSA-N 1,4-diiodobutane Chemical compound ICCCCI ROUYUBHVBIKMQO-UHFFFAOYSA-N 0.000 description 1
- JBUUDSWCICQALC-UHFFFAOYSA-N 1,5-dibromo-3-ethylpentane Chemical compound BrCCC(CC)CCBr JBUUDSWCICQALC-UHFFFAOYSA-N 0.000 description 1
- SGRHVVLXEBNBDV-UHFFFAOYSA-N 1,6-dibromohexane Chemical compound BrCCCCCCBr SGRHVVLXEBNBDV-UHFFFAOYSA-N 0.000 description 1
- NJOKEOCKKQCATL-UHFFFAOYSA-N 1-(chloromethyl)-2-(3-chloropropyl)benzene Chemical compound ClCCCC1=CC=CC=C1CCl NJOKEOCKKQCATL-UHFFFAOYSA-N 0.000 description 1
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- JQCSUVJDBHJKNG-UHFFFAOYSA-N 1-methoxy-ethyl Chemical group C[CH]OC JQCSUVJDBHJKNG-UHFFFAOYSA-N 0.000 description 1
- ONSRTKHYXFFKFD-UHFFFAOYSA-N 2-(3-ethylhexan-3-yl)propanedioic acid Chemical compound CCCC(CC)(CC)C(C(O)=O)C(O)=O ONSRTKHYXFFKFD-UHFFFAOYSA-N 0.000 description 1
- YAQLSKVCTLCIIE-UHFFFAOYSA-N 2-bromobutyric acid Chemical compound CCC(Br)C(O)=O YAQLSKVCTLCIIE-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- QUSWUSRPBIWVKF-UHFFFAOYSA-N 2-methyl-6-phenoxyhexan-1-ol Chemical compound OCC(C)CCCCOC1=CC=CC=C1 QUSWUSRPBIWVKF-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- PFEOZHBOMNWTJB-UHFFFAOYSA-N 3 MP Natural products CCC(C)CC PFEOZHBOMNWTJB-UHFFFAOYSA-N 0.000 description 1
- ALZLTHLQMAFAPA-UHFFFAOYSA-N 3-Methylbutyrolactone Chemical compound CC1COC(=O)C1 ALZLTHLQMAFAPA-UHFFFAOYSA-N 0.000 description 1
- MKPLJZUJXIBZMJ-UHFFFAOYSA-N 3-[4-(chloromethyl)phenyl]propanoic acid Chemical compound OC(=O)CCC1=CC=C(CCl)C=C1 MKPLJZUJXIBZMJ-UHFFFAOYSA-N 0.000 description 1
- LAMUXTNQCICZQX-UHFFFAOYSA-N 3-chloropropan-1-ol Chemical compound OCCCCl LAMUXTNQCICZQX-UHFFFAOYSA-N 0.000 description 1
- IVKAPFWKLFIYCG-UHFFFAOYSA-N 4-(2-bromoethoxy)benzonitrile Chemical compound BrCCOC1=CC=C(C#N)C=C1 IVKAPFWKLFIYCG-UHFFFAOYSA-N 0.000 description 1
- NMHDEMMOFNSQES-UHFFFAOYSA-N 4-(3-bromopropyl)benzoic acid Chemical compound OC(=O)C1=CC=C(CCCBr)C=C1 NMHDEMMOFNSQES-UHFFFAOYSA-N 0.000 description 1
- QBLISOIWPZSVIK-UHFFFAOYSA-N 4-bromobutoxybenzene Chemical compound BrCCCCOC1=CC=CC=C1 QBLISOIWPZSVIK-UHFFFAOYSA-N 0.000 description 1
- MLOSJPZSZWUDSK-UHFFFAOYSA-N 4-carboxybutyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCCC(=O)O)C1=CC=CC=C1 MLOSJPZSZWUDSK-UHFFFAOYSA-N 0.000 description 1
- BERUOTKXCOOJJM-UHFFFAOYSA-N 4-hydroxy-3-methylbut-2-enoic acid Chemical compound OCC(C)=CC(O)=O BERUOTKXCOOJJM-UHFFFAOYSA-N 0.000 description 1
- AFNGFWSCOUNAJN-UHFFFAOYSA-N 6-bromo-2-methylhexan-1-ol Chemical compound OCC(C)CCCCBr AFNGFWSCOUNAJN-UHFFFAOYSA-N 0.000 description 1
- IPKFFYBHMDNBSC-UHFFFAOYSA-N 6-bromo-2-methylhexanoic acid Chemical compound OC(=O)C(C)CCCCBr IPKFFYBHMDNBSC-UHFFFAOYSA-N 0.000 description 1
- XVWLGESEXBZKEJ-UHFFFAOYSA-N 6-methyl-7-(oxan-2-yloxy)hept-5-enoic acid Chemical compound OC(=O)CCCC=C(C)COC1CCCCO1 XVWLGESEXBZKEJ-UHFFFAOYSA-N 0.000 description 1
- RSFGVEJXKVQYQT-UHFFFAOYSA-N 7-bromo-6-methylhept-5-enoyl bromide Chemical compound BrCC(=CCCCC(=O)Br)C RSFGVEJXKVQYQT-UHFFFAOYSA-N 0.000 description 1
- JSAPFCVAPHVRRH-UHFFFAOYSA-N 7-bromo-6-methylheptanoic acid Chemical compound BrCC(C)CCCCC(O)=O JSAPFCVAPHVRRH-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical group CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 description 1
- RELCLXLYMTZGCF-UHFFFAOYSA-N C(C)OC(CC(CI)C)=O.C(C)OC(C(CCCI)CC)=O Chemical compound C(C)OC(CC(CI)C)=O.C(C)OC(C(CCCI)CC)=O RELCLXLYMTZGCF-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical class NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- NOTFZGFABLVTIG-UHFFFAOYSA-N Cyclohexylethyl acetate Chemical compound CC(=O)OCCC1CCCCC1 NOTFZGFABLVTIG-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- 208000017228 Gastrointestinal motility disease Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- ZIRDFYXDGNKADH-UHFFFAOYSA-N OBr=O.OBr=O.OBr=O.P Chemical compound OBr=O.OBr=O.OBr=O.P ZIRDFYXDGNKADH-UHFFFAOYSA-N 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- VFWVBXMDYQVWDH-UHFFFAOYSA-N [2-(3-chloropropyl)phenyl]methyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1CCCCl VFWVBXMDYQVWDH-UHFFFAOYSA-N 0.000 description 1
- KURZCZMGELAPSV-UHFFFAOYSA-N [Br].[I] Chemical group [Br].[I] KURZCZMGELAPSV-UHFFFAOYSA-N 0.000 description 1
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 description 1
- 125000001539 acetonyl group Chemical group [H]C([H])([H])C(=O)C([H])([H])* 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N benzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyloxyacetoaldehyde Natural products CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 125000005621 boronate group Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- GUPWNYUKYICHQX-UHFFFAOYSA-N carbonobromidic acid Chemical compound OC(Br)=O GUPWNYUKYICHQX-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 150000001940 cyclopentanes Chemical class 0.000 description 1
- WRBBQTRNKVNFIH-UHFFFAOYSA-N diethyl 2-(5-bromo-3-methylpentyl)propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)CCC(C)CCBr WRBBQTRNKVNFIH-UHFFFAOYSA-N 0.000 description 1
- RPNFNBGRHCUORR-UHFFFAOYSA-N diethyl 2-butylpropanedioate Chemical compound CCCCC(C(=O)OCC)C(=O)OCC RPNFNBGRHCUORR-UHFFFAOYSA-N 0.000 description 1
- DQOQGLCPVQXHFF-UHFFFAOYSA-N diethyl 2-methyl-2-(4-phenoxybutyl)propanedioate Chemical compound CCOC(=O)C(C)(C(=O)OCC)CCCCOC1=CC=CC=C1 DQOQGLCPVQXHFF-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 238000010932 ethanolysis reaction Methods 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- JIPWHZOYUGYXFA-GQCTYLIASA-N ethyl (e)-4-bromo-3-methylbut-2-enoate Chemical compound CCOC(=O)\C=C(/C)CBr JIPWHZOYUGYXFA-GQCTYLIASA-N 0.000 description 1
- FHGRPBSDPBRTLS-ONEGZZNKSA-N ethyl (e)-4-bromobut-2-enoate Chemical compound CCOC(=O)\C=C\CBr FHGRPBSDPBRTLS-ONEGZZNKSA-N 0.000 description 1
- CVYKQPLWSDHSSV-UHFFFAOYSA-N ethyl 2-(2-chloroethoxy)acetate Chemical compound CCOC(=O)COCCCl CVYKQPLWSDHSSV-UHFFFAOYSA-N 0.000 description 1
- WWUOQCGCASJPHJ-UHFFFAOYSA-N ethyl 2-(3-chloropropoxy)acetate Chemical compound CCOC(=O)COCCCCl WWUOQCGCASJPHJ-UHFFFAOYSA-N 0.000 description 1
- TWBZBLRWDYAYSD-UHFFFAOYSA-N ethyl 2-(3-iodopropoxy)benzoate Chemical compound CCOC(=O)C1=CC=CC=C1OCCCI TWBZBLRWDYAYSD-UHFFFAOYSA-N 0.000 description 1
- AZQWECRSZHTUSX-UHFFFAOYSA-N ethyl 2-(4-bromobutoxy)propanoate Chemical compound CCOC(=O)C(C)OCCCCBr AZQWECRSZHTUSX-UHFFFAOYSA-N 0.000 description 1
- QUUFPXKCRKQRQF-UHFFFAOYSA-N ethyl 2-(4-iodobutyl)benzoate Chemical compound CCOC(=O)C1=CC=CC=C1CCCCI QUUFPXKCRKQRQF-UHFFFAOYSA-N 0.000 description 1
- ODBGKBWQAKXFIU-UHFFFAOYSA-N ethyl 3-(2-iodoethoxy)benzoate Chemical compound CCOC(=O)C1=CC=CC(OCCI)=C1 ODBGKBWQAKXFIU-UHFFFAOYSA-N 0.000 description 1
- ZUVXKSLGGWDTJZ-UHFFFAOYSA-N ethyl 3-(3-iodopropoxy)propanoate Chemical compound CCOC(=O)CCOCCCI ZUVXKSLGGWDTJZ-UHFFFAOYSA-N 0.000 description 1
- XZZDVSAQTDAMLA-UHFFFAOYSA-N ethyl 3-[3-(bromomethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC=CC(CBr)=C1 XZZDVSAQTDAMLA-UHFFFAOYSA-N 0.000 description 1
- LLACVNYOVGHAKH-UHFFFAOYSA-N ethyl 3-propoxypropanoate Chemical compound CCCOCCC(=O)OCC LLACVNYOVGHAKH-UHFFFAOYSA-N 0.000 description 1
- NYSADWJQUICPEE-UHFFFAOYSA-N ethyl 4-methyl-heptanoate Chemical compound CCCC(C)CCC(=O)OCC NYSADWJQUICPEE-UHFFFAOYSA-N 0.000 description 1
- YDRFUQMSLPYQCI-UHFFFAOYSA-N ethyl 5-(bromomethyl)furan-2-carboxylate Chemical compound CCOC(=O)C1=CC=C(CBr)O1 YDRFUQMSLPYQCI-UHFFFAOYSA-N 0.000 description 1
- AFRWBGJRWRHQOV-UHFFFAOYSA-N ethyl 5-bromopentanoate Chemical compound CCOC(=O)CCCCBr AFRWBGJRWRHQOV-UHFFFAOYSA-N 0.000 description 1
- NOMYBDXNJPRUJJ-UHFFFAOYSA-N ethyl 6-ethyl-8-iodooctanoate Chemical compound CCOC(=O)CCCCC(CC)CCI NOMYBDXNJPRUJJ-UHFFFAOYSA-N 0.000 description 1
- DOXQODVJBLUBKS-UHFFFAOYSA-N ethyl 6-methylheptanoate Chemical compound CCOC(=O)CCCCC(C)C DOXQODVJBLUBKS-UHFFFAOYSA-N 0.000 description 1
- XWHCWZYTIPGVLD-UHFFFAOYSA-N ethyl 7-bromo-4-methylheptanoate Chemical compound CCOC(=O)CCC(C)CCCBr XWHCWZYTIPGVLD-UHFFFAOYSA-N 0.000 description 1
- VMIBXGDYRRTQMO-UHFFFAOYSA-N ethyl 7-iodoheptanoate Chemical compound CCOC(=O)CCCCCCI VMIBXGDYRRTQMO-UHFFFAOYSA-N 0.000 description 1
- PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 1
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- PPXUHEORWJQRHJ-UHFFFAOYSA-N ethyl isovalerate Chemical compound CCOC(=O)CC(C)C PPXUHEORWJQRHJ-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- BBMCPEOFGAIHQK-HWKANZROSA-N methyl (e)-4-bromo-3-methylbut-2-enoate Chemical compound COC(=O)\C=C(/C)CBr BBMCPEOFGAIHQK-HWKANZROSA-N 0.000 description 1
- GSJFXBNYJCXDGI-UHFFFAOYSA-N methyl 2-hydroxyacetate Chemical compound COC(=O)CO GSJFXBNYJCXDGI-UHFFFAOYSA-N 0.000 description 1
- BBMCPEOFGAIHQK-UHFFFAOYSA-N methyl 4-bromo-3-methylbut-2-enoate Chemical compound COC(=O)C=C(C)CBr BBMCPEOFGAIHQK-UHFFFAOYSA-N 0.000 description 1
- 125000004492 methyl ester group Chemical group 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000004540 pour-on Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 239000002089 prostaglandin antagonist Substances 0.000 description 1
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000007296 regulation of reproductive process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/14—Preparation of carboxylic acid nitriles by reaction of cyanides with halogen-containing compounds with replacement of halogen atoms by cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/08—Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/19—Acids containing three or more carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Devices Affording Protection Of Roads Or Walls For Sound Insulation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2331081A DE2331081A1 (de) | 1973-06-19 | 1973-06-19 | Neue cyclopentanderivate und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH620893A5 true CH620893A5 (es) | 1980-12-31 |
Family
ID=5884394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH827774A CH620893A5 (es) | 1973-06-19 | 1974-06-17 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3984459A (es) |
| JP (1) | JPS5036445A (es) |
| AT (1) | AT367035B (es) |
| AU (1) | AU7018774A (es) |
| BE (1) | BE816566A (es) |
| CA (1) | CA1049509A (es) |
| CH (1) | CH620893A5 (es) |
| DE (1) | DE2331081A1 (es) |
| DK (1) | DK326474A (es) |
| ES (1) | ES427198A1 (es) |
| FR (1) | FR2233989B1 (es) |
| GB (1) | GB1466298A (es) |
| HU (1) | HU175237B (es) |
| NL (1) | NL7407998A (es) |
| SE (1) | SE7407942L (es) |
| ZA (1) | ZA743883B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5223048A (en) * | 1975-08-15 | 1977-02-21 | Teijin Ltd | Preparation of prostaglandin derivatives |
| FR2353287A1 (fr) * | 1975-08-29 | 1977-12-30 | Roussel Uclaf | Nouveaux derives du cyclopentanol, leur procede de preparation et leur application comme medicaments |
| DE2548814A1 (de) * | 1975-10-31 | 1977-05-26 | Hoechst Ag | Neue cyclopentanderivate und verfahren zu ihrer herstellung |
| FR2332971A1 (fr) * | 1975-11-26 | 1977-06-24 | Roussel Uclaf | Nouveaux derives de la cyclopentanone, leur procede de preparation et leur application a la synthese de prostaglandines |
| US4055407A (en) * | 1976-11-01 | 1977-10-25 | Ppg Industries, Inc. | Apparatus for the manufacture of flat glass having a glass refractory delivery piece and method of installation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3868402A (en) * | 1971-04-28 | 1975-02-25 | Roussel Uclaf | Novel cyclopentanone-2-carboxylates |
| US3849474A (en) * | 1972-03-27 | 1974-11-19 | Ayerst Mckenna & Harrison | 11-deoxyprostaglandin derivatives and process therefor |
-
1973
- 1973-06-19 DE DE2331081A patent/DE2331081A1/de not_active Withdrawn
-
1974
- 1974-06-07 CA CA201,962A patent/CA1049509A/en not_active Expired
- 1974-06-12 ES ES427198A patent/ES427198A1/es not_active Expired
- 1974-06-14 NL NL7407998A patent/NL7407998A/xx not_active Application Discontinuation
- 1974-06-17 SE SE7407942A patent/SE7407942L/xx unknown
- 1974-06-17 CH CH827774A patent/CH620893A5/de not_active IP Right Cessation
- 1974-06-17 US US05/480,319 patent/US3984459A/en not_active Expired - Lifetime
- 1974-06-18 AT AT0503574A patent/AT367035B/de not_active IP Right Cessation
- 1974-06-18 HU HU74HO1679A patent/HU175237B/hu unknown
- 1974-06-18 DK DK326474A patent/DK326474A/da unknown
- 1974-06-18 AU AU70187/74A patent/AU7018774A/en not_active Expired
- 1974-06-18 ZA ZA00743883A patent/ZA743883B/xx unknown
- 1974-06-19 GB GB2714274A patent/GB1466298A/en not_active Expired
- 1974-06-19 BE BE145625A patent/BE816566A/xx not_active IP Right Cessation
- 1974-06-19 JP JP49070076A patent/JPS5036445A/ja active Pending
- 1974-06-19 FR FR7421339A patent/FR2233989B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| SE7407942L (es) | 1974-12-20 |
| CA1049509A (en) | 1979-02-27 |
| FR2233989A1 (es) | 1975-01-17 |
| DK326474A (es) | 1975-02-10 |
| DE2331081A1 (de) | 1975-01-23 |
| AU7018774A (en) | 1975-12-18 |
| US3984459A (en) | 1976-10-05 |
| ATA503574A (de) | 1981-10-15 |
| AT367035B (de) | 1982-05-25 |
| JPS5036445A (es) | 1975-04-05 |
| ZA743883B (en) | 1975-07-30 |
| BE816566A (fr) | 1974-12-19 |
| NL7407998A (es) | 1974-12-23 |
| HU175237B (hu) | 1980-06-28 |
| GB1466298A (en) | 1977-03-02 |
| FR2233989B1 (es) | 1978-07-21 |
| ES427198A1 (es) | 1976-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4112236A (en) | Interphenylene 8-aza-9-dioxothia-11,12-secoprostaglandins | |
| US4175203A (en) | Interphenylene 11,12-secoprostaglandins | |
| EP0033156B1 (de) | 1-Phenyl-2-cyclohexen-1-alkylamin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE2755759A1 (de) | 4-(4-acyl-3-hydroxy-8-methyltridecyl)- benzoesaeuren | |
| CH620893A5 (es) | ||
| DE3107743A1 (de) | Neue klasse von acylderivaten des carnitins, verfahren zu deren herstellung sowie ihre therapeutische verwendung | |
| DE2346706A1 (de) | Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung | |
| DE2550004C2 (de) | Thiaprostaglandine sowie Verfahren zu ihrer Herstellung | |
| DE2610503C2 (de) | Optisch aktive 13,14-Dehydro-11- desoxy-prostaglandine, Verfahren zu ihrer Herstellung und sie enthaltendes pharmazeutisches Mittel | |
| EP0001270A1 (de) | Neue Prostacyclin-Analoga, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung von Herzkreislauf-Krankheiten | |
| AT391866B (de) | Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine | |
| CH617676A5 (es) | ||
| CH653028A5 (de) | Benzthiophenallylamin-verbindungen und verfahren zu ihrer herstellung. | |
| DE2452536A1 (de) | Pyrrolidone und verfahren zu ihrer herstellung | |
| US4083990A (en) | Cyclopentane derivatives | |
| CH615659A5 (en) | Process for the preparation of novel 11,12-secoprostaglandins | |
| DE3518655A1 (de) | Neue phenolderivate, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel | |
| DE1793825C3 (de) | 2-(6'-substituierte-2'-Naphthyl)propionsäurederivate und deren Herstellung | |
| JPS581118B2 (ja) | １５↓−置換↓−ω↓−ペンタノルプロスタグランジン誘導体 | |
| DE2618721C2 (de) | Benzo(b)-bicyclo[3,3,1]nonene, Verfahren zu deren Herstellung und pharmazeutische Mittel, die diese Verbindungen enthalten | |
| DE2917178C2 (es) | ||
| EP0069880B1 (de) | Cyclopentanonderivate und Verfahren zu deren Isomerisierung | |
| AT347423B (de) | Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und von deren salzen | |
| AT256090B (de) | Verfahren zur Herstellung von neuen Indenderivaten sowie deren 2,3-Dihydroverbindungen | |
| DE3818570A1 (de) | Neue 6-substituierte-4-hydroxy-tetrahydro-pyran -2-on-derivate, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |